|
MCL1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.838000E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.795800E-01 |
| Normal-vs-Stage2 |
8.830600E-01 |
| Normal-vs-Stage3 |
2.191000E-01 |
| Normal-vs-Stage4 |
5.185800E-01 |
| Stage1-vs-Stage2 |
3.195000E-01 |
| Stage1-vs-Stage3 |
1.135740E-03 |
| Stage1-vs-Stage4 |
4.403600E-02 |
| Stage2-vs-Stage3 |
2.773000E-01 |
| Stage2-vs-Stage4 |
6.154800E-01 |
| Stage3-vs-Stage4 |
4.881200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.923600E-01 |
| Normal-vs-AfricanAmerican |
7.420600E-01 |
| Normal-vs-Asian |
7.871400E-01 |
| Caucasian-vs-AfricanAmerican |
6.889000E-01 |
| Caucasian-vs-Asian |
7.510800E-01 |
| AfricanAmerican-vs-Asian |
7.020000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.069800E-01 |
| Normal-vs-Female |
3.505400E-01 |
| Male-vs-Female |
2.189800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.065600E-01 |
| Normal-vs-Age(41-60Yrs) |
8.054400E-01 |
| Normal-vs-Age(61-80Yrs) |
7.839600E-01 |
| Normal-vs-Age(81-100Yrs) |
7.958000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.782000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.140200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.668000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.950200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.640800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.961400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.073410E-01 |
| Normal-vs-Grade 2 |
2.786800E-01 |
| Normal-vs-Grade 3 |
3.817400E-01 |
| Normal-vs-Grade 4 |
3.512400E-01 |
| Grade 1-vs-Grade 2 |
2.039000E-01 |
| Grade 1-vs-Grade 3 |
1.044440E-02 |
| Grade 1-vs-Grade 4 |
1.087890E-02 |
| Grade 2-vs-Grade 3 |
2.521200E-03 |
| Grade 2-vs-Grade 4 |
1.095620E-02 |
| Grade 3-vs-Grade 4 |
8.304200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.693800E-01 |
| Normal-vs-ccB subtype |
6.370400E-01 |
| ccA subtype-vs-ccB subtype |
6.091900E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.358000E-01 |
| Normal-vs-N1 |
6.397600E-01 |
| N0-vs-N1 |
6.360600E-01 |
|
|
